Medical/Pharmaceuticals

SIFI receives positive CHMP opinion for AKANTIOR® (polihexanide 0.08%) in acanthamoeba keratitis

ACI SANT'ANTONIO, Italy, May 31, 2024 /PRNewswire/ -- SIFI announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of AKANTIOR® (polihexanide under the international non-proprietary name),...

2024-05-31 15:00 1589

Record numbers expected at CPHI & PMEC China 2024 as Asian markets boom

Domestic and international markets in Asia surging as CPHI & PMEC China welcomes 60,000 attendees and 3500 exhibitors SHANGHAI and AMSTERDAM, May 31, 2024 /PRNewswire/ -- CPHI & PMEC China  (June 19-21st) returns to the Shanghai New International Expo Center amid s...

2024-05-31 11:18 1775

One in Six Globally Concerned About Colorectal Cancer Screening Costs

SHENZHEN, China, May 31, 2024 /PRNewswire/ -- By 2040, the burden of colorectal cancer (CRC) is projected to increase to 3.2 million new cases and 1.6 million deaths per year representing a 66% and 71% rise in new cases and deaths respectively relative to2020

2024-05-31 08:00 2600

Telix Announces Positive rPFS Data from ProstACT SELECT Trial of TLX591 rADC Therapy Candidate in Prostate Cancer

* TLX591 is an investigational anti-PSMA[1] radio-antibody-drug conjugate (rADC) therapy being developed for the treatment of mCRPC, differentiated by a short two-week dosing regimen. * Reported median radiographic progression-free survival (rPFS) is 8.8 months. * Builds on prior data from th...

2024-05-31 07:19 2019

LumaCina announces availability of Oral Morphine pain medication for New Zealanders

PERTH, Australia and MIAMI, May 31, 2024 /PRNewswire/ -- LumaCina, the pharmaceutical supplier and marketing division ofBridgewest Perth Pharma announce new production of Oral Morphine to meet critical drug shortage inNew Zealand. The shortfall of Oral Morphine has become increasingly concerning...

2024-05-31 05:17 1886

SOPHiA GENETICS Launches Global Consortium, SOPHiA UNITY, to Accelerate Cancer Research, Drug Development, and Data-Driven Patient Care

New collective intelligence network to enable the most advanced research in oncology in support of precision medicine BOSTON and ROLLE, Switzerland, May 30, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medici...

2024-05-31 01:18 1711

TOOsonix receives MDR CE Mark for its new oncology and dermatology device

The EU Medical Device Regulation CE certification approves that the most common types of skin cancer and a wide range of skin diseases and conditions can be treated in less than 90 seconds. COPENHAGEN, Denmark, May 30, 2024 /PRNewswire/ -- TOOsonix A/S, a pioneer in high-intensity focused ultras...

2024-05-30 21:23 1443

Teikoku Pharma USA, Inc. Announces NMPA Approved Lidoderm® in China on May 8, 2024

SAN JOSE, Calif., May 30, 2024 /PRNewswire/ -- Teikoku Pharma USA (TPU) announced today that the NMPA (National Medical Products Administration) has approved Lidoderm® ("lidocaine 5% patch as lidocaine cataplasms") for the treatment of Post Herpetic Neuralgia (PHN) inChina. TPU entered into an e...

2024-05-30 21:15 1439

ZEISS announces OCT technology enhancements to better support growing era of data-driven patient care

ZEISS Medical Ecosystem fortifies the CIRRUS 6000 with the U.S. market's largest OCT reference database and advanced cybersecurity features. DUBLIN, Calif., May 30, 2024 /PRNewswire/ -- ZEISS Medical Technology announced today that the CIRRUS® 6000 from ZEISS now enables a highly efficient and d...

2024-05-30 21:00 1816

Metabolon Announces 4-Week Turnaround Time for Commercial Projects, Enhancing Metabolomic Services for Multiomic Research

MORRISVILLE, N.C., May 30, 2024 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, today announced a significant enhancement to its serv...

2024-05-30 20:57 1342

Preliminary Clinical Data on Relma-Cel Injection in Adults with Active Systemic Lupus Erythematosus in China at the Eular 2024 Congress

SHANGHAI, May 30, 2024 /PRNewswire/ -- JW (Cayman) Therapeutics Co. Ltd (the "Company" or "JW Therapeutics", together with its subsidiaries, the "Group"), an independent and innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products, pres...

2024-05-30 18:10 2934

Beame Expands Global Footprint

Dr. Philip Fan J.P. (范榮彰博士) Spearheads Provision of Premium Dental Services Aspiring to Benefit More People Worldwide HONG KONG, May 30, 2024 /PRNewswire/ -- Beame, a Hong Kong dental company founded by Dr.Philip Fan, J.P. (范榮彰博士), the former Chairman of the Board of Directors, Tung Wah Group of...

2024-05-30 12:27 1981

Tigermed Advances Clinical Data Management with Veeva Vault EDC

Modern EDC streamlines key processes to accelerate study builds and make mid-study amendments with no downtime SHANGHAI, May 30, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV), the global leader in cloud solutions for the life sciences industry, today announced that Hangzhou Tigermed Consulting...

2024-05-30 09:38 2380

Soterios Pharma Announces Positive Topline Results from Phase II Study of STS-01 in the Treatment of Mild / Moderate Alopecia Areata

* Once-daily topical treatment of mild / moderate alopecia areata (AA) with 1% STS-01 met the primary efficacy endpoint of >30% Severity of Alopecia Tool (SALT) score improvement compared to patients receiving placebo (p<0.0096) * Multiple secondary endpoints met with significant total hair re...

2024-05-30 07:05 3371

Veritas Genetics at the forefront of genomic screening with new studies presented at the European Society of Human Genetics Conference - ESHG 2024

* Veritas will present two pioneering studies at the European Society of Human Genetics Conference, inBerlin from June 1 to June 4. With a focus on elective genomic screening and newborn genomic screening, Veritas aims to set new standards in preventive medicine. * The Conference, now in its...

2024-05-29 17:55 1900

Onconic Therapeutics Announces Positive Phase 3 Results for JAQBO at Digestive Diseases Week 2024

SEOUL, South Korea and WASHINGTON, May 29, 2024 /PRNewswire/ -- Onconic Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for oncology and gastrointestinal disorders, announced today the results of its Phase 3 ZERO-1 study of JAQBO (zastaprazan...

2024-05-29 17:35 2235

Frost & Sullivan Reported The Fourth Revolutionary Wave of Biologics Manufacturing: CDMOs Empower Large-scale Production of Biologics

SHANGHAI, May 29, 2024 /PRNewswire/ -- Recently, Frost & Sullivan released the report "The Fourth Revolutionary Wave of Biologics Manufacturing: CDMOs Empower Large-scale Production of Biologics".  I.  CDMOs are advancing the biopharmaceutical industry with superior biomanufacturing capabilities...

2024-05-29 14:08 1771

Spectacular advances creating a revolution in the diagnosis and treatment of male infertility

MANILA, Philippines, May 29, 2024 /PRNewswire/ -- Spectacular advances in the diagnosis and treatment of male infertility are offering new hope to the one in six couples globally who seek assisted reproduction to achieve their dreams of parenthood. A major conference on human reproduction in t...

2024-05-29 12:42 1567

US-Based Neurobiotic Leader Bened Life enters Japan market with Neuralli™ MP

FREMONT, Calif., May 29, 2024 /PRNewswire/ -- Bened Life , the leader in psychobiotics, has begun worldwide expansion after finding success inthe United States with Neuralli™ MP - the first gut-brain medical probiotic for neurological conditions. With investment from Teij...

2024-05-29 10:00 2453

SKT Launches AI-powered Veterinary Diagnostic Assistance Service X Caliber in Australia

* In collaboration with ATX Medical Solutions, SKT launches X Caliber in Australia, which has one of the highest rates of pet ownership in the world * SKT also inked a commercial contract with MEDIVET Pet Hospital & Clinic to offer X Caliber inIndonesia. SEOUL, South Korea, May 29, 2024 /PRNew...

2024-05-29 08:32 1482
1 ... 33343536373839 ... 396